Share Name Share Symbol Market Type Share ISIN Share Description
IQE LSE:IQE London Ordinary Share GB0009619924 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +15.50p +12.55% 139.00p 134.20p 137.10p 137.10p 123.00p 124.10p 12,188,490 16:35:08
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Technology Hardware & Equipment 132.7 19.0 2.9 48.4 1,049.11

IQE (IQE) Latest News

More IQE News
IQE Takeover Rumours

IQE (IQE) Share Charts

1 Year IQE Chart

1 Year IQE Chart

1 Month IQE Chart

1 Month IQE Chart

Intraday IQE Chart

Intraday IQE Chart

IQE (IQE) Discussions and Chat

IQE Forums and Chat

Date Time Title Posts
24/2/201817:39IQE's time has come - 2017 and beyond!14,478
14/2/201813:17BANNED from the Iqe thread - how absurd62
08/2/201816:37Time to sell IQE?305
02/2/201816:03IQE Long term holders (no ramping/deramping)6
23/11/201722:09IQE - TURNED A CORNER, SET TO RISE29,626

Add a New Thread

IQE (IQE) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all IQE trades in real-time

IQE (IQE) Top Chat Posts

DateSubject
24/2/2018
08:20
IQE Daily Update: IQE is listed in the Technology Hardware & Equipment sector of the London Stock Exchange with ticker IQE. The last closing price for IQE was 123.50p.
IQE has a 4 week average price of 89p and a 12 week average price of 89p.
The 1 year high share price is 181.50p while the 1 year low share price is currently 45.50p.
There are currently 754,756,394 shares in issue and the average daily traded volume is 5,295,626 shares. The market capitalisation of IQE is £1,049,111,387.66.
10/2/2018
14:57
crazycoops: At 180p there was an argument to say the IQE share price had run ahead of itself. A bear case on valuation grounds at that price was reasonable as there was plenty of hot money involved. At £1 it looks like the bull case on valuation grounds is much stronger, once again. 2017 results to be published in March will be ahead of expectations. 2018 and 2019 guidance is likely to lead to significant broker upgrades. It will be interesting to see which shorters hang around for results day and which ones try to exit beforehand. It will also be interesting to see if any IIs decide to start buying in volume and when. I suspect the shorts that are well in the money from 180p down will have a different mindset to those that have joined the party a little late in the day.Tick tock!
05/2/2018
07:35
bulltradept: Good to see a decent rebuttal. However the IC still has this as a sell, here is the piece from this week's IC: "IQE’s big short By Megan Boxall There is much to be said about investing in momentum. The past few years in particular have provided investors in many UK companies with a virtuous circle of good news, share price surges, rising capital and, thus, more good news. But when that sentiment reverses, company share prices have a habit of coming unstuck quickly. That is what has happened at semiconductor specialist IQE (IQE). Following a 379 per cent share price rise between January and November 2017, the shares have since fallen 41 per cent from their 52-week high. Sure, at 108p they are still 173 per cent higher than this time last year, but investors who only jumped on the IQE bandwagon in the past couple of months will be nursing heavy losses. Driving the change in momentum is the growing presence of hedge funds on the shareholder register. Following the increased holding of Marshall Wace earlier in January, IQE is now the fourth most shorted company on the London Stock Exchange, with 11.8 per cent of its shares being bet against. In fact, Marshall Wace’s 4.3 per cent short position gives it the fifth biggest interest in the group. The hedge fund is not alone in its concerns. Six other managers have short positions of more than 0.5 per cent, T Rowe Price – IQE’s single biggest shareholder – recently disposed of 5.5m shares and five more of the group’s top 10 largest investors have reduced their positions since November. IQE develops and sells advanced wafers for use in semiconductors. For example, its vertical-cavity surface-emitting laser (VCSEL) is a crucial component in the facial recognition technology of the iPhone X. For many years, the group has enjoyed a dominant market position, which has been unassailable due to the challenges in developing competitive products. But now, the short sellers seem convinced that IQE’s market-leading position is under threat. Moreover, the group is slightly dependent on its contract with Apple(US:AAPL). Driving the change in momentum is the growing presence of hedge funds on the shareholder register So, are the hedge funds right to be concerned, and should private investors follow their lead and get out now? House broker Peel Hunt thinks not. In December, the broker upgraded its earnings expectations for both 2018 and 2019 by 10 per cent to take account of “an even better outlook”. In fact, all five of the brokers that regularly cover IQE suggest investors should keep buying. Admittedly, there are some reasons to remain optimistic about the semiconductor specialist. Global customers are increasingly adopting VCSEL and this is helping to drive up both the volume and quality of revenues. Concerns about IQE’s reliance on Apple can be overstated, according to Peel Hunt analyst Andrew Shepherd-Barron. “The iPhone X contract is an easy hook to hang your hat on, but there is more to VCSELs than smartphones and more to IQE than VCSELs”. In the future, facial recognition technology is likely to be used in a range of devices and “IQE is very well placed”, he said. But history suggests that it may be worth taking note of the hedge funds. Prior to its recent collapse, Carillion was the most shorted stock in the UK, with around 30 per cent of its register betting against it. Simon McGarry, senior equity research analyst at Canaccord Genuity Wealth Management uses the proportion of shorted shares as a useful metric when looking at potential investment opportunities. “Short selling allows hedge funds and other sophisticated market participants to generate returns based on their negative views of a stock. As a result, it provides a valuable price discovery mechanism for financial markets.” To that end, holders of Provident Financial (PFG) and Debenhams (DEB) – which top the depressing roster of Britain’s most shorted companies – have reason to be wary. Investors in both have had to stomach major profit warnings in the past few months and, if the short sellers are proved correct, their woes may not yet be behind them. IC View Following the hedge funds can be a risky business. Any glimmer of good news from a heavily shorted company causes the short sellers to quickly close out their positions, leading to an artificially inflated share price. This so-called short squeeze hurts Ocado (OCDO) bears every time the company puts out an announcement. However, when it comes to IQE we agree that investors are best off taking a step back. At 30 times 2018 forecast earnings, the valuation may look more palatable than six months ago. However, given the threat of rising competition, we see no reason to get back into a stock that is still falling. Sell at 108p. Last IC View: Sell, 146p, 6 Sep 2017
05/2/2018
07:08
multibagger: IQE plc : Response to ShadowFall report GNW 5 February 2018 IQE plc ("IQE" or the "Company") Response to ShadowFall report IQE plc (AIM: IQE) notes the report published by ShadowFall Capital & Research LLP ("ShadowFall"), which was disseminated to the public on 2 February 2018. The allegations contained within the report are without merit and provide a misleading analysis of the Company's financial position. The central thesis of this report is a fundamental misrepresentation of the profit and cash generation of IQE, especially with respect to the Company's joint venture agreements. IQE would like to directly address the key themes in the report, correct any misinformation that might arise from the report's inaccuracies and assure shareholders that IQE holds itself to the highest standards of corporate governance, transparency and integrity. It is also important to note that ShadowFall states that it holds a short position in IQE and so will duly profit from any near-term reduction in IQE's share price, caused by the allegations in the report. ShadowFall made no attempt to review its report with IQE prior to its publication. The purpose of IQE's joint ventures The joint ventures in Singapore and Cardiff form an important part of IQE's strategy to be at the leading edge of compound semiconductor innovation, through collaboration with leading universities and supply chain partners. These joint ventures have independent third-party shareholders and are governed by standalone boards, separate management teams and joint venture agreements that establish governance procedures and decision making. As a member of the joint ventures, IQE participates in these boards, but does not have control. These joint ventures are independently audited. The creation of the joint venture in Cardiff was the first cornerstone entity in the development of a globally recognised UK compound semiconductor cluster (CS Connected), which is seeking to create and sustain over 2,000 high skilled, well paid manufacturing jobs for the local and UK economy. This is already making a significant impact in the local economy, including saving 500 jobs in Newport Wafer Fab Ltd, which had been scheduled for closure by its previous owner, the creation of a UK Government funded Compound Semiconductor Applications Catapult, and a number of major technology development programmes between Cardiff University, the joint venture, IQE and a number of major OEMs in South Wales. Transactions with joint ventures IQE's trade with these joint ventures is clearly reported in the notes to its annual reports and financial statements. The nature of this trade is IQE sub-contracting certain external customer contracts through these joint ventures. By acting as an anchor customer, IQE is providing the joint ventures with initial business to limit their start up losses in their early years of operation. By agreement with its joint venture partners, these transactions are undertaken at cost, and hence this does not impact IQE's cost of production or increase its profits. The joint ventures have subsequently been successful with new business wins, some of which have been contracted directly with new customers in 2017 with no direct involvement of IQE. License income from IQE intellectual property License income from joint ventures has been reported in detail by the Company in regulatory announcements and in its annual reports and financial statements. In these reports, IQE has made it clear that license income from joint ventures was front-loaded, reflecting the creation of their initial capability to serve commercial contracts. As noted in its most recent trading update, IQE's license income from joint ventures will be less than £2 million in 2017. Profit & loss of joint ventures The only profits that IQE has earned from the joint ventures is a book profit on the initial contribution on fixed assets in the setup of the Cardiff joint venture, and through the licensing of its intellectual property to both joint ventures. In the case of the Cardiff joint venture (CSC), the consideration for intellectual property licensing has been a combination of cash and receivable long-term loans. Both sources of consideration have been clearly stated in IQE's annual reports and financial statements. The revenue that the joint venture generates from IQE meets the cash cost of the joint venture's operation, at no financial gain or loss to IQE. The EBITDA loss of the joint venture in 2016 was £0.7 million, representing the cost of its own management, business development, and administration. The joint venture also has non-cash charges for amortisation of its intellectual property license and a depreciation of assets which gives a net loss of £4.4 million. This has been detailed in IQE's annual reports & financial statements. The ShadowFall report implies that IQE has used the joint venture to "hide" costs of IQE's own business, which is inaccurate. In the case of the Singapore joint venture (CSDC), to support this business through its start up years, IQE has licensed intellectual property and leased surplus Molecular Beam Epitaxy ("MBE") capacity to the joint venture on a contingent basis, namely these charges only become payable by the joint venture to IQE to the extent that the joint venture generates surplus cash in each year. As required by International Financial Reporting Standards ("IFRS"), the joint venture fully reflects these costs in its own accounts, whereas IQE only accounts for this as income when it has been received in cash. Excluding these contingent charges, the Singapore joint venture generated cash of approximately £2 million from its operations in 2016, and hence paid approximately £2 million of license income to IQE in that year. Asset valuation In order to reduce overall set up costs, IQE contributed certain fixed assets to the Cardiff joint venture in return for its equity stake. This was undertaken at market value, as determined by an independent professional valuer mutually agreed by the joint venture partners. Cardiff University match funded this value in cash in return for its equity stake in the joint venture. Similarly, the valuation of the intellectual property was validated by an independent accounting firm in a report to the joint venture board. EBITDA and free cash generation The difference between IQE's EBITDA and its free cash generation can be readily identified from IQE's annual reports and financial statements, namely (a) investment in R&D and capital expenditure and (b) an acquisition in 2012 which was paid for through an earnout, as detailed below. In 2012, IQE acquired the MBE epi-wafer manufacturing unit of RF Micro Devices ("RFMD"), with the acquisition consideration being settled through a trade discount on sales by IQE to RFMD for a fixed period of 4 years. In accordance with IFRS, this discount was classified as part of working capital. This was described in the Company's annual reports and financial statements and detailed in the notes to the cash flow statement. Had the Company financed this acquisition through debt or equity finance, the payment to acquire this business would have been excluded from the calculation of the free cash generation. As previously reported, this discount period ended in 2016. IQE now fully owns the acquired facility in North Carolina (original cost $110 million) and RFMD (now Qorvo) remains a key customer for IQE. Outlook As stated in the Company's pre-close statement on 20 December 2017, the Company re-iterates that it expects full year revenue to be ahead of market expectations, and to be not less than £150 million for the year ending 31 December 2017. Wafer sales are on track to deliver strong double-digit growth in 2017 and to continue to diversify, while annual growth in Photonics is also expected to achieve triple-digit growth. The Company remains confident in its outlook for 2018 and beyond. The Group is scheduled to report its full year results for 2017 on 20 March 2018, and will provide forward looking guidance at that time.
04/2/2018
18:32
steve davies: Rega s clockwork I echo your praise for the positive contributions today clearly there is expertise worth listening to. This B.B. seems to be influenced be a few people who claim in-depth knowledge and personal relationshiops within IQE that clearly does not stack up with iqe share price. Have iqe long term interest in mind ie positive, but not swayed by strategically timed contributors, and ‘technical experts’ looking at marketing PR material from suppliers. Either you are a consistent contributor or you are someone with an agenda.
04/2/2018
09:32
aphrodites: How many times have posters here asked, what do the shorters know that we don’t? Now we all know and the set-up stinks. As I have already posted, the fact that the ShadowFall report appeared to be leaked on Friday and coincided with a very weak Wall Street together with the two scum-bags entering the fray, is all part of a very clever and finely planned and coordinated attack on the IQE share price. And you can put money on all the papers' business editors having received the report on Friday so that the maximum damage can be wrought on the share price on Monday. You only have to see comments from the likes of “bookbroker221; above to get an idea as to how the share price will react on Monday. Words alone in The Times and a feeble assurance by IQE that all is well, will not prevent the shorters from pulling the carpet from under the feet of the Market Makers on Monday. The damage is already done. And a threat of legal action by the CEO will only repeat the Quindell fiasco. Even if “thecrunckR17;s” analysis is accurate and the Board of IQE are not a load of crooks, this needs much, much stronger action to reassure the market and to teach these shorters a lesson. There is only one course of action. Get the company to ask for the share price to be suspended first thing on Monday with a statement they will be publishing a report in the next few days which will totally refute ShadowFall’s statements about IQE’s joint ventures and bring forward the results at the same time. More importantly, if the ShadowFall report is shown to be totally inaccurate, the FCA needs to take immediate action. It cannot continue to allow the market to be duped by inaccurate reports which allow those who short shares to profit and make millions from their dubious and dishonest manipulations. Note: my comments are made with the proviso the IQE Board can be relied upon, which I believe they can. THE TIME HAS COME FOR ACTION!
02/2/2018
11:27
bocase: Chessmaster: I don't think for a moment that the hedge funds know something we don't. They are just being logical. IQE share price spiked last year like no other and 90% of the time the price that has spiked will regress to the norm (200 day moving average or whatever) so the hedge funds were just playing the odds. The are no different from bookies and many if not all are already in profit so they were right. So are we, however. It is just a matter of time. Faith and Patience!!
01/2/2018
10:18
hannath: Just out on Investors Chronicle .... IQE’s big short Be the first to comment IQE’s big short By Megan Boxall There is much to be said about investing in momentum. The past few years in particular have provided investors in many UK companies with a virtuous circle of good news, share price surges, rising capital and, thus, more good news. But when that sentiment reverses, company share prices have a habit of coming unstuck quickly. That is what has happened at semiconductor specialist IQE (IQE). Following a 379 per cent share price rise between January and November 2017, the shares have since fallen 41 per cent from their 52-week high. Sure, at 108p they are still 173 per cent higher than this time last year, but investors who only jumped on the IQE bandwagon in the past couple of months will be nursing heavy losses. Driving the change in momentum is the growing presence of hedge funds on the shareholder register. Following the increased holding of Marshall Wace earlier in January, IQE is now the fourth most shorted company on the London Stock Exchange, with 11.8 per cent of its shares being bet against. In fact, Marshall Wace’s 4.3 per cent short position makes it the fifth biggest investor in the group. IQE:LSE IQE PLC 1mth Today change 0.19% Price (GBP) 107.00 The hedge fund is not alone in its concerns. Six other managers have short positions of more than 0.5 per cent, T Rowe Price – IQE’s single biggest shareholder – recently disposed of 5.5m shares and five more of the group’s top 10 largest investors have reduced their positions since November. IQE develops and sells advanced wafers for use in semiconductors. For example, its vertical-cavity surface-emitting laser (VCSEL) is a crucial component in the facial recognition technology of the iPhone X. For many years, the group has enjoyed a dominant market position, which has been unassailable due to the challenges in developing competitive products. But now, the short sellers seem convinced that IQE’s market-leading position is under threat. Moreover, the group is slightly dependent on its contract with Apple (US:AAPL). So, are the hedge funds right to be concerned, and should private investors follow their lead and get out now? House broker Peel Hunt thinks not. In December, the broker upgraded its earnings expectations for both 2018 and 2019 by 10 per cent to take account of “an even better outlook”. In fact, all five of the brokers that regularly cover IQE suggest investors should keep buying. Admittedly, there are some reasons to remain optimistic about the semiconductor specialist. Global customers are increasingly adopting VCSEL and this is helping to drive up both the volume and quality of revenues. Concerns about IQE’s reliance on Apple can be overstated, according to Peel Hunt analyst Andrew Shepherd-Barron. “The iPhone X contract is an easy hook to hang your hat on, but there is more to VCSELs than smartphones and more to IQE than VCSELs”. In the future, facial recognition technology is likely to be used in a range of devices and “IQE is very well placed”, he said.
24/1/2018
11:57
jamesrowe: How likely is it that we will read in the papers tomorrow that "IQE fell more that 13% due to a shorter attack"? ANSWER: No chance! The papers will probably say "IQE share price fell yesterday on concerns about Apple iPhone X sales".
21/1/2018
15:42
regasclockwork: Some weeks back I plonked a post on here from monty1965 [iiiBB]. It was well received on here and iii. Although DS told monty he was talking rubbish, the former reluctantly withdrew his remarks and the hatchet is now buried. Monty1965 is a real gentleman and very forgiving as you will see from the following recent post of his. A punter over on iii was interested [as were many others] in knowing what had happened to Sweeney and Monty as neither had posted for quite some time. I think you will enjoy Monty's very informative reply. I think this chap really knows his stuff. Get a crate of light ale on deck, strap yourselves in and prepare for a long and interesting read. Read on - take it away Monty!: I'm very flattered to even be missed, let alone mentioned. Re Dave Sweeney, I believe, though I didn't see it, he suffered a bereavement and posted before New Year that as a result he wouldn't be posting for a while. Re myself, it's Christmas, it's New Year, where do you think I've been??? I've been here all the time, reading the odd post, choosing not to read a bunch of others which I know will be absolute BS and a waste of my time. My job isn't and never has been to post on the bulletin board everyday, like most people I have other things I do. Moreover and most importantly after the Interim Management Statement the company has said everything about the ongoing state of the business and their likely expectations, what do I have to add??? We've already seen the management raise £95m at 140p for 10% of the company. In theory there are 10% more shares in issue and here we are, about 10% lower than on issuance. The fact that the shares went up into the 170's, I never saw them at 180p by the way, not saying they didn't officially touch that level, is of no consequence to me as a long term investor, indeed I'm much more interested by the opportunity the shares offer after the retreat. I've been a consistent buyer at these levels and luckily I currently have one of my other holdings subject to an agreed cash takeover, which will free up £60,000. As of right now I can think of nothing more I'd like to buy than 45,000 or 50,000 more shares in IQE so it's hardly a disaster they've come back a bit, if indeed they stay around here once the takeover proceeds have been received I'll be feeling quite chipper. But let's just consider a few other matters for a minute: 1) tech at the top end i.e. the FAANGS etc have had an incredible year BUT you just need to look at for example the reaction to the Facebook announcement late last week, marked the shares down 4.5% on the day I believe, so at best after all considerations, while not necessarily in a bear market (and why would it be? Technological advancement is the future of/underlies much of the economic growth prospects ongoing) it's obvious that tech stocks, both at the top end and of course further down the scale e.g. IQE are taking a breather - IMHO I don't think it will go on too long and see it as mainly a rotational thing 2) you may have noticed Apple's announcement re Intel chip flaws and security concerns, I don't think this has been exactly bullish for either Apple, tech, or anything related 3) re the specifics of IQE and its rating, of course it had a fantastic run and got a bit stretched perhaps and those who sold in the 160's/170's have been [short term] well rewarded. I didn't as I'm just happy to pick off shares in my target holdings. Everyone has their own style. I buy and hold with a 3-5 year investment horizon. Why would I be anything other than wholly satisfied with the company's performance and their recent update in their IMS??? I recognise short term, and of course it's easier with the benefit of hindsight, that their high rating short term made them vulnerable to retrace back towards 140p i.e. the issue price. The fact they've gone beyond that could well be because of the change in short term sentiment towards tech shares. 4) on the basis, short term at least, that there's an information vacuum between the IMS and the results announcement, and considering all the other points above (the shares had gone up, short term sentiment has turned for tech stocks in general as they pause for breath, the chip security issue hasn't helped that at all) then it's hardly surprising the shares have re-traced a bit. I have no idea if that will continue, I've bought shares at 110p the day they really had a panic, I bought some at 160p one one of my less advised days, so what?? I like the company, I want to own shares in the company. That's not a statement on what's happening over the next half hour, half week or even half a year! REMEMBER, THE COMPANY RUNS ITS BUSINESS BUT NOT ITS SHAREPRICE. That's set by traders and investors. Why does anyone feel that if I put out a bullish post, and I am very bullish of the company, that it has one iota's drop of difference on the company share price. It doesn't. And if it does, the effect would be for nano-minutes!! Dear me. I was a successful (I'd like to think) investment manager for 15 years. A fund I managed for 8 years was rated AA by S&P Fund Research. Maybe I don't understand IQE as a business like many more tech minded people understand it. Maybe I don't understand shares and investing in stock markets as well as I used to having been out of the market as a professional for a few years now with better things to do (although it's one of the most privileged jobs in the world, looking after people's money and accepting their trust to create asset growth for them), but what I do see in IQE is everything I'd ever want to see in a business I'd like to invest in. I've said many times, this is not about 2017 or 2018 earnings. It's about where earnings are expected to be in 2020 and 2021 once we get to 2019 and start looking forward. This is a train leaving a station, not one that's half way down the track. The difference is, if Johnny Cash wants to post every detail of every trade he's done, that's his choice, good luck to him, why do I have to reply??? If WS wants to post his usual piffle, drivel and general loose attempts to wind up others - his de-ramps or whatever he calls them, how can I stop him?? I've just learned to ignore his posts and to seriously question his intentions, which I find for the most part malicious. I think I summed him up recently - the phrase I used was "his tainted milk", I hope it raised a few smiles. I'm not trying to argue for a higher or lower share price, the share price will set itself. What I will say is I'm still very bullish about the company. I believe that there's every reason the share price will be considerably higher than its current level and the previous all time high, 178, 179, 180p or whatever it was... What all investors have to understand, and traders are by their nature impatient beasts, is that the real world of running companies, working with customers and winning contracts, building new factories and capacity, making and selling products, earning profits takes time, it's not a second by second thing unlike the flash of blue or red over the same company's share price as it goes up and down. Investment is also a term that operates on many levels. Those who provided the £95m were genuinely INVESTING in the company i.e. providing fresh capital. The rest of us, as shareholders and owners, probably would happily have done so but it would have taken quite a long time to put the deal together, we weren't needed, so we merely continue as investors in the broader meaning i.e. we own the asset (the shares) to grow our wealth. If I really have something to add, I genuinely will try my best to express my opinion. I hope this helps but meantime while flattered by your concern, I really feel you shouldn't overly worry about my absence. Mr Sweeney understands technological developments better than most, but really the important people are the company's management and board of directors. We employ them to lead, direct and manage the company. From what I've seen so far, I've been pretty pleased over all with their accomplishments and with where they've positioned the company going forward. Anyhow, if I could tick STRONG BUY, I would do so. Is that a ramp enough?? I suspect it will have about as much effect of the share price as it should have whether I put STRONG BUY or SELL i.e. zero. Happy New Year everyone! Best wishes as ever monty1965
18/1/2018
10:03
thecrunk: I am over the Sweenoid topic its closed that was yesterday. I did place a caveat on all my statements that I still beleive in the company. Moving forward positive comment today in Investomania: "IQE has disappointed in the last month, with its share price declining by 15%. However, this may be due to some profit taking, since the investment outlook for the business still seems to be positive in my eyes. The company’s capital raising means it may be able to access further growth opportunities, while a PEG of 0.9 suggests the IQE share price may have a large margin of safety." hxxps://investomania.co.uk/2018/01/5-growth-stocks-i-need-buy-today-prudential-plc-unilever-plc-iqe-plc-astrazeneca-plc-just-eat-plc/
IQE share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20180224 18:15:41